245 related articles for article (PubMed ID: 29475917)
1. How Should Palliative Thoracic Radiotherapy Be Fractionated for Octogenarians with Lung Cancer?
Nieder C; Yobuta R; Mannsåker B; Dalhaug A
In Vivo; 2018; 32(2):331-336. PubMed ID: 29475917
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
3. Palliative thoracic radiotherapy in advanced lung cancer: A single institution experience.
Hotwani C; Agarwal JP; Prabhash K; Munshi A; Joshi A; Misra S; Kumar D; Das S; Laskar SG
Indian J Cancer; 2017; 54(1):262-266. PubMed ID: 29199702
[TBL] [Abstract][Full Text] [Related]
4. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation.
Rutter CE; Park HS; Corso CD; Yeboa DN; Mancini BR; Lester-Coll NH; Kim AW; Decker RH
Lung Cancer; 2015 Nov; 90(2):243-8. PubMed ID: 26277031
[TBL] [Abstract][Full Text] [Related]
5. [Treatment outcome of locally advanced stage IIIA/B lung cancer].
Cicenas S; Zaliene A; Atkocius V
Medicina (Kaunas); 2009; 45(6):452-9. PubMed ID: 19605965
[TBL] [Abstract][Full Text] [Related]
6. Palliative Thoracic Radiotherapy for Lung Cancer: What Is the Impact of Total Radiation Dose on Survival?
Nieder C; Tollali T; Yobuta R; Reigstad A; Flatoy LR; Pawinski A
J Clin Med Res; 2017 Jun; 9(6):482-487. PubMed ID: 28496548
[TBL] [Abstract][Full Text] [Related]
7. A retrospective analysis of survival outcomes for two different radiotherapy fractionation schedules given in the same overall time for limited stage small cell lung cancer.
Bettington CS; Tripcony L; Bryant G; Hickey B; Pratt G; Fay M
J Med Imaging Radiat Oncol; 2013 Feb; 57(1):105-12. PubMed ID: 23374562
[TBL] [Abstract][Full Text] [Related]
8. Impact of the Radiation Dose and Completion of Palliative Radiotherapy on Survival in Patients Treated for Locally Advanced Lung Cancer.
Janssen S; Kaesmann L; Schild SE; Rades D
Anticancer Res; 2016 Apr; 36(4):1825-8. PubMed ID: 27069165
[TBL] [Abstract][Full Text] [Related]
9. Has the pattern of practice in the prescription of radiotherapy for the palliation of thoracic symptoms changed between 1999 and 2006 at the rapid response radiotherapy program?
Fairchild A; Goh P; Sinclair E; Barnes EA; Ghosh S; Danjoux C; Barbera L; Tsao M; Chow E
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):693-700. PubMed ID: 18262087
[TBL] [Abstract][Full Text] [Related]
10. Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy?
Sundstrøm S; Bremnes RM; Brunsvig P; Aasebø U; Kaasa S;
J Thorac Oncol; 2006 Oct; 1(8):816-24. PubMed ID: 17409965
[TBL] [Abstract][Full Text] [Related]
11. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
[TBL] [Abstract][Full Text] [Related]
12. High-dose thoracic radiation therapy at 3.0 Gy/fraction in inoperable stage I/II non-small cell lung cancer.
Kim B; Ahn YC; Lim DH; Nam HR
Jpn J Clin Oncol; 2008 Feb; 38(2):92-8. PubMed ID: 18267986
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Stahl JM; Ross R; Harder EM; Mancini BR; Soulos PR; Finkelstein SE; Shafman TD; Dosoretz AP; Evans SB; Husain ZA; Yu JB; Gross CP; Decker RH
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1011-1020. PubMed ID: 27869080
[TBL] [Abstract][Full Text] [Related]
14. Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party.
Br J Cancer; 1991 Feb; 63(2):265-70. PubMed ID: 1705140
[TBL] [Abstract][Full Text] [Related]
15. Survival after palliative radiotherapy in geriatric cancer patients.
Nieder C; Angelo K; Haukland E; Pawinski A
Anticancer Res; 2014 Nov; 34(11):6641-5. PubMed ID: 25368269
[TBL] [Abstract][Full Text] [Related]
16. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
17. Palliative Thoracic Radiotherapy for Non-small Cell Lung Cancer: Is There any Impact of Target Volume Size on Survival?
Nieder C; Imingen KS; Mannsaker B; Yobuta R
Anticancer Res; 2021 Jan; 41(1):355-358. PubMed ID: 33419831
[TBL] [Abstract][Full Text] [Related]
18. Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter.
Pradier O; Lederer K; Hille A; Weiss E; Christiansen H; Schmidberger H; Hess CF
J Cancer Res Clin Oncol; 2005 Apr; 131(4):261-9. PubMed ID: 15616830
[TBL] [Abstract][Full Text] [Related]
19. Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.
Zhang J; Fan M; Liu D; Zhao KL; Wu KL; Zhao WX; Zhu ZF; Fu XL
Radiat Oncol; 2017 Mar; 12(1):51. PubMed ID: 28283034
[TBL] [Abstract][Full Text] [Related]
20. Split-course palliative radiotherapy for advanced non-small cell lung cancer.
Metcalfe SK; Milano MT; Bylund K; Smudzin T; Rubin P; Chen Y
J Thorac Oncol; 2010 Feb; 5(2):185-90. PubMed ID: 20009771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
